[新聞] 浩鼎:公司將於2/21公布OBI-822乳癌臨床
-------------------------------------------------------------------------
1.發文前請先詳閱[新聞]分類發文規範,未依規範發文將受處份。
2.連結過長請善用 https://goo.gl/ 縮網址,連結能不能點擊者板規4-1處份。
3.心得/評論請盡量充實,心得過短將會以4-4一行文規範水桶處份。
4.請依格式輸入內容,未依格式者板規4-1砍文處份。
---------------------------按ctrl+y可刪除以上內容。----------------------
1.原文連結(必須檢附):
http://goo.gl/8N9jBF
2.原文內容:
證交所重大訊息公告
(4174)浩鼎本公司將於105年2月21日公布OBI-822乳癌臨床試驗之解盲結果
1.事實發生日:105/02/17
2.公司名稱:台灣浩鼎生技股份有限公司
3.與公司關係[請輸入本公司或子公司]:本公司
4.相互持股比例:不適用
5.傳播媒體名稱:不適用
6.報導內容:不適用
7.發生緣由:本公司將於105年2月21日公布OBI-822乳癌臨床試驗之解盲結果。
8.因應措施:不適用
9.其他應敘明事項:
新藥開發時程長、投入經費高且並未保證能一定成功,此等可能使投資
面臨風險,投資人應審慎判斷謹慎投資。
3.心得/評論(必需填寫):
即將於2/21(日)公布新藥結果了,究竟會不會過呢?
即使目前已經借券賣出5,950張了,借券餘額也來到7,434張(至2/16止),
但股價還是相當的硬!
希望浩鼎能過,能造福相關的病患。
--
※ 發信站: 批踢踢實業坊(ptt.cc), 來自: 59.105.177.72
※ 文章網址: https://www.ptt.cc/bbs/Stock/M.1455706818.A.11E.html
推
02/17 19:07, , 1F
02/17 19:07, 1F
→
02/17 19:08, , 2F
02/17 19:08, 2F
→
02/17 19:08, , 3F
02/17 19:08, 3F
推
02/17 19:08, , 4F
02/17 19:08, 4F
推
02/17 19:10, , 5F
02/17 19:10, 5F
→
02/17 19:10, , 6F
02/17 19:10, 6F
推
02/17 19:12, , 7F
02/17 19:12, 7F
→
02/17 19:14, , 8F
02/17 19:14, 8F
推
02/17 19:18, , 9F
02/17 19:18, 9F
→
02/17 19:19, , 10F
02/17 19:19, 10F
→
02/17 19:21, , 11F
02/17 19:21, 11F
推
02/17 19:22, , 12F
02/17 19:22, 12F
→
02/17 19:24, , 13F
02/17 19:24, 13F
→
02/17 19:24, , 14F
02/17 19:24, 14F
推
02/17 19:25, , 15F
02/17 19:25, 15F
推
02/17 19:26, , 16F
02/17 19:26, 16F
→
02/17 19:27, , 17F
02/17 19:27, 17F
推
02/17 19:31, , 18F
02/17 19:31, 18F
推
02/17 19:37, , 19F
02/17 19:37, 19F
推
02/17 19:39, , 20F
02/17 19:39, 20F
推
02/17 19:40, , 21F
02/17 19:40, 21F
推
02/17 19:42, , 22F
02/17 19:42, 22F
推
02/17 19:47, , 23F
02/17 19:47, 23F
噓
02/17 19:50, , 24F
02/17 19:50, 24F
推
02/17 19:56, , 25F
02/17 19:56, 25F
推
02/17 19:57, , 26F
02/17 19:57, 26F
噓
02/17 19:58, , 27F
02/17 19:58, 27F
推
02/17 19:59, , 28F
02/17 19:59, 28F
噓
02/17 20:00, , 29F
02/17 20:00, 29F
→
02/17 20:00, , 30F
02/17 20:00, 30F
推
02/17 20:03, , 31F
02/17 20:03, 31F
推
02/17 20:05, , 32F
02/17 20:05, 32F
→
02/17 20:10, , 33F
02/17 20:10, 33F
推
02/17 20:13, , 34F
02/17 20:13, 34F
→
02/17 20:14, , 35F
02/17 20:14, 35F
推
02/17 20:15, , 36F
02/17 20:15, 36F
推
02/17 20:26, , 37F
02/17 20:26, 37F
噓
02/17 20:31, , 38F
02/17 20:31, 38F
推
02/17 20:34, , 39F
02/17 20:34, 39F
還有 47 則推文
推
02/18 06:40, , 87F
02/18 06:40, 87F
推
02/18 08:18, , 88F
02/18 08:18, 88F
→
02/18 08:19, , 89F
02/18 08:19, 89F
推
02/18 08:43, , 90F
02/18 08:43, 90F
推
02/18 08:58, , 91F
02/18 08:58, 91F
→
02/18 09:35, , 92F
02/18 09:35, 92F
推
02/18 09:37, , 93F
02/18 09:37, 93F
→
02/18 09:40, , 94F
02/18 09:40, 94F
推
02/18 10:15, , 95F
02/18 10:15, 95F
→
02/18 10:16, , 96F
02/18 10:16, 96F
推
02/18 10:24, , 97F
02/18 10:24, 97F
→
02/18 10:45, , 98F
02/18 10:45, 98F
推
02/18 10:58, , 99F
02/18 10:58, 99F
推
02/18 11:35, , 100F
02/18 11:35, 100F
推
02/18 11:46, , 101F
02/18 11:46, 101F
→
02/18 11:47, , 102F
02/18 11:47, 102F
推
02/18 11:51, , 103F
02/18 11:51, 103F
→
02/18 11:51, , 104F
02/18 11:51, 104F
→
02/18 11:51, , 105F
02/18 11:51, 105F
→
02/18 11:52, , 106F
02/18 11:52, 106F
推
02/18 11:57, , 107F
02/18 11:57, 107F
→
02/18 11:57, , 108F
02/18 11:57, 108F
推
02/18 12:22, , 109F
02/18 12:22, 109F
推
02/18 12:33, , 110F
02/18 12:33, 110F
推
02/18 12:53, , 111F
02/18 12:53, 111F
推
02/18 13:12, , 112F
02/18 13:12, 112F
推
02/18 13:36, , 113F
02/18 13:36, 113F
推
02/18 13:36, , 114F
02/18 13:36, 114F
推
02/18 13:49, , 115F
02/18 13:49, 115F
推
02/18 13:50, , 116F
02/18 13:50, 116F
→
02/18 13:52, , 117F
02/18 13:52, 117F
推
02/18 14:11, , 118F
02/18 14:11, 118F
→
02/18 16:36, , 119F
02/18 16:36, 119F
推
02/18 17:10, , 120F
02/18 17:10, 120F
噓
02/18 22:09, , 121F
02/18 22:09, 121F
推
02/18 23:11, , 122F
02/18 23:11, 122F
→
02/18 23:12, , 123F
02/18 23:12, 123F
噓
02/19 11:44, , 124F
02/19 11:44, 124F
推
02/20 22:48, , 125F
02/20 22:48, 125F
推
02/22 20:01, , 126F
02/22 20:01, 126F
討論串 (同標題文章)
以下文章回應了本文:
完整討論串 (本文為第 1 之 3 篇):